홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 파머슈티컬 > 감염질환 > U.S. Infectious Disease Diagnostics Markets
카테고리
파머슈티컬 (4931)
감염질환 (349)
골질환 치료 (38)
당뇨병 (194)
백신 (181)
비만치료/다이어트 (44)
비처방 의약품 (152)
수의학 (17)
신경질환 (174)
신약개발 (1529)
암치료 (941)
약물전달 (185)
의약품 규제환경 (127)
정신질환 (86)
제네릭 의약품 (128)
제약회사분석 (523)
처방약 (165)
시장보고서

U.S. Infectious Disease Diagnostics Markets

리서치사 Frost & Sullivan
발행일 2006년 04월 상품코드 38052
페이지 정보
가격
US $ 6,000 ￦ 7,149,000 Web Access (Regional License)
US $ 6,500 ￦ 7,744,700 Hard Copy & Web Access (Regional License)


영문목차

Abstract

Market Overview

The U.S. infectious disease diagnostics market will play a significant role in the dynamic IVD market. This market is segmented according to molecular, immunoassays, and culture infectious disease products. Total market revenues for base year 2005 are $3,823.1 with a CAGR of 7.7%. The most substantial growth is expected in the molecular segment. The U.S. infectious disease diagnostics market is highly competitive and saturated

Tremendous growth opportunities exist in the U.S. infectious disease in-vitro diagnostics market. High growth areas include viral load testing, nosocomial infection screening, rapid influenza detection, and STD testing.

Rapid detection and fast turn-around time (TAT) are able to lower total overall healthcare costs. Quick TAT is especially relevant to infectious disease testing, as fast diagnosis increases treatment options and patient prognosis.

Technical superiority of molecular methods is phasing out other types or more traditional methods, such as culture based tests, which have TATs of only days and are labor intensive.

Table of Contents

  • 1. Executive Summary
    • 1. Executive Summary
      • 1. Executive Summary
  • 2. Total Infectious Disease Diagnostics Market
    • 1. Market Overview
      • 1. Introduction
      • 2. Research Methodology
      • 3. Market Engineering Analysis
    • 2. Market Forecasts and Market Share Analysis
      • 1. Scope and Segmentation
      • 2. Market and Technology Trends
      • 3. Market Forecasts
      • 4. Market Share Analysis
    • 3. Market Challenges and Strategic Recommendations
      • 1. Industry Challenges
      • 2. Strategic Recommendations
  • 3. Molecular Infectious Disease Diagnostics Market
    • 1. Market Overview and Forecasts
      • 1. Introduction
      • 2. Market Engineering Measurements
      • 3. Revenue Forecast
    • 2. Market Drivers and Restraints
      • 1. Market Drivers
      • 2. Market Restraints
    • 3. Competitive Analysis
      • 1. Competitive Structure
      • 2. Market Share Analysis
      • 3. Product Analysis
  • 4. Immunoassay Infectious Disease Diagnostics Market
    • 1. Market Overview and Forecasts
      • 1. Introduction
      • 2. Market Engineering Measurements
      • 3. Revenue Forecast
    • 2. Market Drivers and Restraints
      • 1. Market Drivers
      • 2. Market Restraints
    • 3. Competitive Analysis
      • 1. Competitive Structure
      • 2. Market Share Analysis
      • 3. Product Analysis
  • 5. Culture Infectious Disease Diagnostics Market
    • 1. Market Overview and Forecasts
      • 1. Introduction
      • 2. Market Engineering Measurements
      • 3. Revenue Forecast
    • 2. Market Drivers and Restraints
      • 1. Market Drivers
      • 2. Market Restraints
    • 3. Competitive Analysis
      • 1. Competitive Structure and Market Share Analysis
      • 2. Product Analysis
  • 6. Appendix
    • 1. Decision Support Database
      • 1. Global Incidence of TB
      • 2. Global Reported AIDS Cases
      • 3. Global AIDS Mortality Rates
      • 4. Global Incidence of Haemophilus Type B
      • 5. Global Incidence of Hepatitis A
      • 6. Global Incidence of Hepatitis B
      • 7. Global HIV Prevalence
      • 8. Global Incidence of Malaria
      • 9. Global Cases of Rubella
      • 10. Global Incidence of Syphilis
      • 11. U.S. Initial Physician Visit for Genital Herpes
      • 12. U.S. Incidence of Haemophilus Influenzae
      • 13. U.S. Cases of Chlamydia
      • 14. U.S. Cases of Gonorrhea
      • 15. U.S. Cases of West Nile Virus

.

Back to Top